HUM vs LGN · P/E 39, rev $117.76B vs rev $708.0M
Humana Inc (HUM) versus Legence Corp. Class A Common stock (LGN) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Legence Corp. Class A Common stock (LGN) is a engineering & construction company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported LGN revenue for 2025-09-30 was $708.0M. Net income was $379.0K. Revenue was up 26.2% from 2024-09-30 to 2025-09-30. LGN currently screens at market cap $14.66B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. LGN currently screens at market cap $14.66B.
Not investment advice. Open the HUM and LGN stock pages for the full models.
Not investment advice.